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Background: Magnetic resonance (MR) imaging has been described as the most important medical innovation in
the last 25 years. Over 80 million MR procedures are now performed each year and on average 2.3% (95%
confidence interval: 2.0 to 2.5%) of all patients scheduled for MR imaging suffer from claustrophobia. Thus,
prevention of MR imaging by claustrophobia is a common problem and approximately 2,000,000 MR procedures
worldwide cannot be completed due to this situation. Patients with claustrophobic anxiety are more likely to be
frightened and experience a feeling of confinement or being closed in during MR imaging. In these patients,
conscious sedation and additional sequences (after sedation) may be necessary to complete the examinations.
Further improvements in MR design appear to be essential to alleviate this situation and broaden the applicability
of MR imaging. A more open scanner configuration might help reduce claustrophobic reactions while maintaining
image quality and diagnostic accuracy.
Methods/Design: We propose to analyze the rate of claustrophobic reactions, clinical utility, image quality, patient
acceptance, and cost-effectiveness of an open MR scanner in a randomized comparison with a recently designed
short-bore but closed scanner with 97% noise reduction. The primary aim of this study is thus to determine
whether an open MR scanner can reduce claustrophobic reactions, thereby enabling more examinations of
claustrophobic patients without incurring the safety issues associated with conscious sedation. In this manuscript
we detail the methods and design of the prospective “CLAUSTRO” trial.
Discussion: This randomized controlled trial will be the first direct comparison of open vertical and closed short-
bore MR systems in regards to claustrophobia and image quality as well as diagnostic utility.
Trial Registration: ClinicalTrials.gov: NCT00715806
Background
Magnetic resonance (MR) imaging has been described as
the most important medical innovation in the last 25 years
[1]. There has been an enormous increase in the use of
this modality in the clinical setting. Over 80 million MR
procedures are now performed each year worldwide. For
an MR scan, patients typically have to be placed in a long,
narrow tube [2]. Thus, claustrophobia preventing MR ima-
ging is a common problem. Between 1% and 15% of all
patients scheduled for MR imaging suffer from claustro-
phobia and cannot be imaged, or they require sedation to
complete the scan (mean: 2.3%; 95% confidence interval:
2.0% to 2.5%) [3]. Thus it can be estimated that worldwide
approximately 2,000,000 MR procedures cannot be per-
formed or are prematurely terminated due to claustropho-
bia. At an average cost of € 500 per MR imaging, this is
equal to a loss of productivity of € 1 billion, which is an
important financial loss for the health care system. There-
fore, claustrophobia is not only a common problem that
prevents many patients from benefiting from the findings
obtained with MR imaging but also represents an impor-
tant socioeconomic issue for the health care system.
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be frightened and experience a feeling of confinement
or being closed in during MR imaging [4,5]. Those
anxious patients have been reported to experience claus-
trophobia in up to 35% of all cases [6]. In these patients
conscious sedation and additional sequences (after seda-
tion) may be necessary to complete the examinations.
This situation involves significant risks of adverse events
[7-9] and is associated with extra costs because it
reduces workflow, limits patient acceptance, and wastes
valuable scanning time. Improving comfort during MR
imaging (mainly reduction of noise and sensations of
confinement by a fairly panoramic view) appears to be
essential to avoid claustrophobic reactions [10,11]. The
positive effect of noise reduction and improved patient-
centered design (short and wide bore) has recently been
shown in a large cohort study in over 55,000 patients
using a newly designed closed MR unit (with 97% noise
reduction and cylindrical CT-like appearance) with
1.5-T field and up to 45 mT/m gradient strength [3].
However, even on such recent scanners, claustrophobic
patients cannot undergo MR imaging without potentially
life-threatening sedation.
A more open vertical scanner configuration might be
an alternative, but until recently such systems operated at
rather low field strengths (0.2 T), resulting in poor image
quality especially in imaging of the brain [12]. Thus,
recently introduced open MR scanners with an all-
around view and both high field (1.0 T) and high gradient
strength (up to 26 mT/m) might be a valuable clinical
alternative to further reduce claustrophobia while main-
taining diagnostic image quality and diagnostic accuracy
[13,14]. The more all-around view from the inside of
open MR scanners is likely to reduce the incidence of
claustrophobia. However, new closed MR scanners with
patient-centered design (short and wide bore) and noise
reduction have also been shown to greatly reduce claus-
trophobic reactions by a factor of up to 3 [3]. Neverthe-
less, no direct comparison of these two scanner types in
regards to claustrophobia and image quality as well as
diagnostic utility has been performed thus far. Therefore,
it is unclear whether an open vertical or a closed short-
bore MR design is more effective in reducing claustro-
phobia that prevents MR imaging. Moreover, by itself the
design of open MR scanners cannot guarantee a reduc-
tion in claustrophobia or an improvement in patient out-
come. The most decisive evidence for judging the efficacy
of diagnostic tests comes from randomized comparisons
in which the controlled design eliminates the biases of
observational studies [15,16]. Randomized trials are
needed to define the clinical role of such open MR scan-
ners in patients with claustrophobic anxiety. Also no
study has addressed which specific scanner design
patients would prefer for imaging. Therefore, this study
is designed to determine whether an open vertical or a
closed short-bore MR design is more effective in alleviat-
ing claustrophobic anxiety preventing MR imaging and
which further improvements might be necessary to
reduce claustrophobia during MR imaging.
Methods/Design
Primary and secondary objectives
We propose to analyze the rate of claustrophobic reac-
tions and clinical utility of an open MR scanner in a
randomized comparison with a recently designed short-
bore but closed scanner with 97% noise reduction. This
trial will be the first to appraise the potential for claus-
trophobia reduction and clinical relevance of open MR
scanners in claustrophobic patients with a clinical indi-
cation for MR imaging. Furthermore, this trial will ana-
lyze and compare the cost-effectiveness of the two MR
scanners, which is important in view of the enormous
annual loss of healthcare productivity due to claustro-
phobia during MR imaging. Also, patient preferences
and image quality will be analyzed. Thus, this rando-
mized trial may have the potential to influence both the
clinical and economical utilization of MR imaging. If an
open MR scanner can be shown to reduce claustropho-
bia in a randomized comparison it might be justified to
recommend this approach for routine clinical applica-
tion in certain high-risk anxiety patients or in certain
imaging centers.
The primary aim of this study is thus to determine the
ability of an open MR scanner to reduce claustrophobic
reactions, thereby expanding the use of MRI in patients
with claustrophobic anxiety. To achieve this, claustropho-
bic reactions (while entering the scanner room or during
the MR procedure) that prevent MR imaging without
sedation will be compared in the two randomized study
groups. Thus, the question to be answered by this project
is whether an open vertical or a short-bore MR design will
alleviate claustrophobia that prevents MR imaging to a
greater extent. The main secondary aims are the correla-
tion of patients’ scores in several validated psychological
self-report questionnaires with the occurrence of claustro-
phobic events, the duration of MR imaging in the two
groups, and to systematically analyze if and what further
design improvements might be necessary to reduce claus-
trophobia during MR imaging in the future. Therefore,
patient preferences concerning MR scanner design will be
determined (Figure 1, Table 1). These insights are impor-
tant to be able to define which further improvements by
vendors might be necessary to reduce claustrophobic reac-
tions during MR imaging.
Further secondary aims are the influence of MR ima-
ging results on clinical management in the two groups,
cost-effectiveness of the two scanners, image quality
achieved in claustrophobic patients using the two
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to the diagnostic procedure in the two randomized
study groups, and the development of patients’ anxiety
during 4 to 6 weeks and 7 months after MR imaging.
Design
This is a randomized controlled trial of patients with
reported claustrophobia during prior MR imaging or
with the inability to undergo MR imaging in conven-
tional scanners. Eligible patients will be randomly
assigned to one of the following study groups. 1) The
open MR scanner: imaging will be performed in a state-
of-the-art scanner with a vertical magnetic field and
360° open design and 1-T field strength (Panorama,
Philips, Figure 2A) [14], and 2) A state-of-the-art MR
scanner (control group) without an open design but
significant noise reduction of 97% (to below 99 dB(A))
and patient-centered design (short and wide bore) with
1.5-T field strength, which has already been shown to
reduce claustrophobia by a factor of 3 compared with
conventional MR scanners (Magnetom Avanto, Siemens,
Figure 2B) [3]. The study design is shown in Figure 3.
In order to improve patient acceptance, patients who
are assigned to imaging in one MR scanner but cannot
bear this procedure due to claustrophobia will not be
sedated (with conscious sedation according to the stan-
dards of the American Society of Anesthesiology) [17],
but will be cross-referred to imaging in the other scan-
ner in order to preclude adverse events associated with
sedation (Figure 3) [7-9]. This will also allow direct
comparison of the two options in those patients as an
ancillary study, which would otherwise be unethical. If
patients cannot tolerate imaging in the first MR scanner
in which they are assigned without claustrophobic reac-
tions, this will be categorized as an event for the pri-
mary hypothesis of this project. In case patients cannot
undergo imaging in either of the two scanners, con-
scious sedation according to the standards of the Ameri-
can Society of Anesthesiology will be performed (using
Dormicum IV) to enable imaging [17].
Anxiety will be measured using different validated psy-
chological self-report questionnaires such as the Spiel-
berger State-Trait Anxiety Inventory [STAI] [18], the
“Fragebogen zu körperbezogenen Ängsten, Kognitionen
und Vermeidung [AKV]” [19], the Fear Survey Schedule
[FSS-III] [20], and the Claustrophobia Questionnaire
[CLQ] [21].
This randomized study has been approved by the local
institutional review board at Charité. The clinical experi-
ments will be performed according to the DECLARA-
TION OF HELSINKI - Ethical Principles for Medical
Research Involving Human Subjects and the Medizin-
produktgesetz (German Medicinal Products Law).
This is an investigator-sponsored industry-indepen-
dent study.
Patients
Patients with reported claustrophobia during MR ima-
ging or with inability to undergo MR imaging in con-
ventional scanners because of claustrophobic anxiety
will be eligible for the study and subsequent randomiza-
tion if they have a clinical indication for MR imaging of
the head, spine, or shoulder. Patients must not have any
absolute or relative contraindication to MR imaging for
s a f e t yr e a s o n s[ 2 2 ] ,m u s tn o th a v eab o d yw e i g h to f
more than 200 kg (maximum table weight), will be pri-
marily examined without conscious sedation, and have
to be at least 18 years old. Patients must have at least
moderate levels of anxiety towards claustrophobic situa-
tions as determined using the Claustrophobia Question-
naire [CLQ] [21] (an arithmetic mean of at least 1.0
Figure 1 Drawings of four MR scanners which will be used in
the custom-made questionnaire to assess which specific MR
scanner design is evaluated to be the most attractive. Patients
will be asked to rank the four MR scanner types according to their
preferences. First, this assessment will be done assuming equal
diagnostic utility of the MR scanners, and second, assuming for
scanner A good, for scanner B very good, for scanner C moderate
and for scanner D adequate diagnostic utility. Panel A shows the
open MR scanner with a vertical magnetic field design and 1-T field
strength (Panorama, Philips). Panel B shows the closed MR scanner
with a short- and wide-bore design and 1.5-T field strength
(Magnetom Avanto, Siemens). Panel C shows an open MR scanner
with a one column design and a 0.4-T vertical magnetic field. Panel
D shows a MR scanner with a 0.6-T horizontal magnetic field and a
top/front-open design which allows upright positioning of the
patient, while patients have to be examined in supine position on
the scanners A-C. This information will allow defining which further
improvements by the vendors might be necessary to reduce
claustrophobic reactions during MR imaging.
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for each of 26 items). All patients will have to give writ-
ten informed consent before randomization.
Sample size and statistical analysis
We expect claustrophobia rates in this high-risk patient
cohort of 20% in the control group (recent closed short-
bore MR imaging) and 5% in the intervention group
(open MR imaging). With 82 evaluable patients per
group we will achieve the desired power of 80%. Conser-
vatively taking into account an expected drop-out rate
of 5%, a total of 174 patients, 87 per group, have to be
allocated.
The assumed claustrophobia rates are based on 1) all
previous publications on claustrophobia during MR ima-
ging as summarized [3], 2) an expected prevalence of
claustrophobic reactions in conventional MR scanners
in the study population of at least 60%, and 3) the ability
of both open and the recently designed short-bore but
closed MR scanners to significantly reduce claustropho-
bia preventing MR imaging to approximately 5 and 20%,
respectively, as indicated in recent nonrandomized pilot
studies [3,13,14].
The primary endpoint, claustrophobia that prevents
MR imaging, will be evaluated in the intention-to-treat
population using a c
2 test. Secondary endpoints will be
evaluated by parametric or nonparametric analysis of
variance or Mantel-Haenszel tests according to scaling.
Appropriate parameters of effect size (e.g., odds ratios)
with confidence intervals will be calculated. Subgroups
(e.g., sex, age groups, direction of scanning [head-first
vs. feet-first]) will be analyzed exploratively.
Validated questionnaires, MR imaging and need for
further improvements
Validated written self-report questionnaires addressing
anxiety in general and anxiety related to MR imaging
will be used. These include the following: the Spielber-
ger State-Trait Anxiety Inventory [STAI] [18], the “Fra-
gebogen zu körperbezogenen Ängsten, Kognitionen und
Table 1 Summary of the items addressed in the custom-made questionnaire to assess satisfaction with the MR scan
and preferences concerning MR scanner design
Item Range
Preparation and information Excellent/Good/Satisfactory/Fair/Poor
Concern Not at all/Very little/Little/High/Very high
Comfort Excellent/Good/Satisfactory/Fair/Poor
Feeling helpless/embarrassed Not at all/Little/Moderate/Strong/Very strong
Anxiety Horizontal visual analogue scale of 10 cm (0-100)
Noise Horizontal visual analogue scale of 10 cm (0-100)
Pain Horizontal visual analogue scale of 10 cm (0-100)
Complications Yes/No/If yes, which complications
Reasons for premature termination (if applicable) Free text
Reasons for successful completion (if applicable) Free text
Willingness to undergo future examinations on the MR scanner Yes/No/Maybe
General satisfaction with the MR scan Excellent/Good/Satisfactory/Fair/Poor
Summary
Advantages/Disadvantages of the respective MR scanner Free text
Ranking of four MR scanners of different design assuming equal diagnostic utility (Figure 1) 1 to 4
Ranking of four MR scanners assuming different diagnostic utility (Figure 1) 1 to 4
Ranking of the two MR scanners used in the study (Figure 2) 1 to 2
Advantages/Disadvantages of the two MR scanners used in the study Free text
Figure 2 Drawings of the two MR scanners to which patients
will be randomized in the study. Panel A shows the open MR
scanner with a vertical magnetic field with 1.0-T field strength
(Panorama, Philips), up to 26 mT/m gradient strength, acoustic
scanner noise of maximum 150 dB(A), and a 0.45 m high and 1.6 m
wide patient aperture (0.7 m wide patient table). Panel B shows the
closed MR scanner with 1.5-T field strength, up to 45 mT/m
gradient strength, 97% noise reduction to below 99 dB(A), and a
conical shaped wide (0.6 m) and short (1.5 m) bore resembling the
gantry of a computed tomography scanner, which has been shown
to reduce claustrophobia by a factor of 3 (Magnetom Avanto,
Siemens).
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Page 4 of 15Figure 3 Chart of CLAUSTRO study design. The diagram depicts the randomization procedure, patient flow, and data analysis.
Abbreviations: AKV = Fragebogen zu körperbezogenen Ängsten, Kognitionen und Vermeidung [19]. BDI-II = Beck Depression Inventory II [24].
CF = Consent Form. CLQ = Claustrophobia Questionnaire [21]. FSS-III = Fear Survey Schedule III [20]. RWCCL = Revised Ways of Coping Checklist
[29]. STAI = State-Trait Anxiety Inventory [18].
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[FSS-III] [20], and the Claustrophobia Questionnaire
[CLQ] [21]. Also further nonvalidated custom-designed
questionnaires will be used to address patient prefer-
ences concerning MR scanner design and which specific
scanner design they consider most attractive (Figure 1,
Table 1). This information is important to be able to
define which further improvements by vendors might be
necessary to reduce claustrophobia during MR imaging.
Furthermore, patient characteristics, patient satisfaction,
clinical outcome, and development of claustrophobia
will be addressed (Table 2 and 3). All patients will be
asked to again complete some of the questionnaires 4-6
weeks and 7 months after MR imaging. Patients can
send back the completed questionnaires to the study
coordinator using prepaid envelopes that are sent
together with the questionnaires.
Initial assessment
Immediately after enrollment, patients will complete the
above-mentioned questionnaires (German versions of
STAI [18], AKV [19], FSS-III [20], and CLQ [21]; and a
custom-made questionnaire addressing patient character-
istics, Table 2). As depression has been shown to influ-
ence anxiety-coping in phobic patients [23], and anxiety
can be a symptom of depressive disorders, depression
symptoms will be explored using the revised Beck
Depression Inventory [BDI-II] [24]. General health-
related quality of life will be assessed using the EuroQol
questionnaire [EQ-5D] [25]. All questionnaires which
will be used for initial assessment are described below.
The Claustrophobia Questionnaire [CLQ] [21]
The German version of the Claustrophobia Question-
naire consists of 26 items which assess two separate but
related fears hypothesized to comprise claustrophobia:
the fear of suffocation (e.g., “having a bad cold and find-
ing it difficult to breathe through your nose”)a n dt h e
fear of restriction (e.g., “locked in a small dark room
without windows for 15 min”). For each item anxiety is
rated on a scale from 0 (not at all anxious) to 4 (extre-
mely anxious). Summary test scores range from 0 (no
anxiety) to 104 (maximum anxiety). The CLQ will be
used to determine patients’ levels of anxiety toward
claustrophobic situations. As an inclusion criterion
patients must reach an arithmetic mean of at least 1.0
in the CLQ (equal to a summary score of at least 26) to
be eligible for randomization.
The Spielberger State-Trait Anxiety Inventory [STAI] [18]
The German version of the Spielberger State-Trait
Anxiety Inventory is based on two questionnaires (State
Table 2 Summary of items addressed in the custom-made questionnaire for initial assessment
Item Range
School graduation German secondary schools (Hauptschule, Realschule, Gesamtschule)/Grammar school/
GDR schools (EOS, POS)
Leaving school after grade Free text
Last or current profession If not employed: Pensioner/Unemployed
Gross family income per month €0-500/500-1000/1000-1500/1500-2000/2000-2500/2500-3000/3000-4000/4000-5000/>
5000
Marital status Single/Living with partner/Married/Divorced/Living apart/Single mother or father/
Widowed
Number of Children/Number of children under 18 years Free text
Current extent of claustrophobia Horizontal visual analogue scale of 10 cm (0-100)
Claustrophobia during MR imaging in the past Yes/No/If yes description
Claustrophobia preventing prior scheduled MR imaging Yes/No/If yes description
When did claustrophobic anxiety occur for the first
time
Free text
Ideas or strategies to cope with anxiety before and
during MR imaging
Yes/No/If yes description*
Belief in successful completion of MR imaging (self-
efficacy)
Yes/No/Maybe
Fear of diagnostic findings by MR imaging Yes/No
Medication Yes/No/If yes which drugs and dosage
Psychosomatic or psychiatric diseases Yes/No/If yes which diseases
Previous or current psychotherapy Yes/No/If yes what kind and how long
*Coping strategies will be categorized according to the Revised Ways of Coping Checklist (RWCCL) [29].
Abbreviations:
EOS = “Erweiterte Oberschule”.
GDR = German Democratic Republic.
POS = “Polytechnische Oberschule”.
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from 1 (almost never) to 4 (very much so). The items
are short statements, e.g., “I feel nervous and restless”.
The State questionnaire consists of 10 positive and 10
negative items which assess the current state of anxiety.
The Trait questionnaire consists of 13 positive and 7
negative items assessing the general state of anxiety.
Summary test scores range from 20 (no anxiety) to 80
(maximum anxiety).
The Fear Survey Schedule [FSS-III] [20]
The Fear Survey Schedule was originally developed to
assess change in phobic behavior and generalized anxiety
in conditioning therapy. The revised and extended FSS-
III has been designed for clinical use. The version of the
FSS-III used here consists of 78 items measuring fear,
phobic behavior, and generalized anxiety. Each item is a
phrase of 2-6 words (e.g., “Being in an elevator”)f o r
which a person rates anxiety on a scale from 1 (not at all)
to 4 (very much). There are 6 subclassifications of fear in
the FSS-III: animal fears (9 items), social and interperso-
nal fears (18 items), fears of tissue damage, illness, death
and their associations (19 items), noise fears (4 items),
other classical phobias (20 items), and miscellaneous
fears such as strange places, falling, failure, imaginary
creatures, strange shapes, feeling angry, dull weather, or
making mistakes (8 items). According to Lukins et al. 9
items of the FSS reflect a range of aversive characteristics
of the MR imaging procedure: vacuum cleaner noise,
being alone, loud noises, being in an elevator, enclosed
places, and journeys by airplane [26]. Summary fear
scores range from 0 to 312.
The „Fragebogen zu körperbezogenen Ängsten, Kognitionen
und Vermeidung [AKV]” [19]
The AKV is the German version of the Body Sensations
Questionnaire (BSQ), the Agoraphobic Cognitions
Questionnaire (ACQ), and the Mobility Inventory (MI)
of Chambless et al. [27]. The AKV consists of three sys-
tems for the diagnosis of anxiety and somatoform
Table 3 Summary of items addressed in the custom-made follow-up questionnaire
Item Range
Examination, Result, Treatment
MR findings have revealed the reason for current medical
condition (from patients’ point of view)
Yes/No
The diagnostic findings obtained by MR imaging have already
been known
Yes/No
The diagnostic findings have led to consequences in treatment Yes/No/If Yes:
Conservative treatment/Surgery/Other (patients are asked to add the medical
report or the name of the attendant doctor/hospital)
Additional diagnostic findings by other examinations Yes/No/If yes, which diagnoses (patients are asked to add the medical report
or the name of the attendant doctor/hospital)
Improvement of medical condition during the last 7 months Yes/No/If yes:
Without treatment/After treatment/After another measure
Claustrophobia
Current extent of claustrophobia Horizontal visual analogue scale of 10 cm (0-100)
Attempts to alleviate claustrophobia during the last 7 months Yes/No/If yes:
Psychotherapy/Drugs/Own problem-solving methods
Willingness to start therapy if possible Yes/No
Time willing to investigate in ambulant or stationary therapy Nothing/Up to how much time per month/year
Money willing to investigate in therapy (in addition to health
insurance contribution)
Nothing/Up to how much money per month/year
Satisfaction
Initial assessment and information about the study Very good/Good/Satisfactory/Fair/Not at all
Option to see the MR scanners prior to imaging Very good/Good/Satisfactory/Fair/Not at all
Information about MR imaging Very good/Good/Satisfactory/Fair/Not at all
MR imaging Very good/Good/Satisfactory/Fair/Not at all
Delivery of diagnostic findings Very good/Good/Satisfactory/Fair/Not at all
Further MR imaging Yes/No/If Yes, of which anatomical region and why
Hypothetical willingness to take part in the study again Yes/No
Willingness to undergo another MR imaging at the Department
of Radiology at Charité Berlin
Yes/No
Would you recommend others to have a scheduled MR imaging
at the Department of Radiology at Charité Berlin
Yes/No
Requests, comments, criticism Free text
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anxiety and somatoform disorders:
-T h e“Fragebogen zur Angst vor körperlichen
Symptomen” (BSQ, German version) explores the
fear of body sensations as internal triggers of anxiety.
The questionnaire consists of 17 items (e.g., “heart
palpitations”) for which anxiety is rated on a scale
from 1 (not at all) to 5 (extremely). Summary scores
range from 17 to 85. Patients will be asked to report
which three of the 17 body sensations occur most
frequently when they are anxious or nervous.
-T h e“Fragebogen zu angstbezogenen Kognitionen”
(ACQ, German version) explores the tendency to
catastrophizing cognitions and apprehensions which
can come along with body sensations. There are two
subscales: the “loss of control” subscale (e.g., “Ia m
going to go crazy”)a n dt h e“physiological conse-
quences” subscale (e.g., “I will have a heart attack”),
each with 7 items. For all items occurrence in situa-
tions of anxiety is rated on a scale from 1 (never) to
5 (always). Summary scores range from 14 to 70.
Patients will be asked to report which three of the
14 cognitions occur most frequently when they are
anxious or nervous.
-T h e“Mobilitätsinventar” (MI, German version)
explores the extent and complexity of phobic avoidance
behavior referring to external triggers of anxiety. The
questionnaire consists of 27 items describing the most
important agoraphobic situations (e.g., “elevators”). For
each item avoidance is rated twice for “being alone”
and “in company” on a scale from 1 (never) to 5
(always). Summary scores range from 54 to 270.
The Beck Depression Inventory (BDI-II) [24]
The Beck Depression Inventory is one of the most widely
used self-report measures of depression. The German
version of the revised Beck Depression Inventory (BDI-
II) consists of 21 items comprising the diagnostic criteria
for Major Depressive Disorder according to the Diagnos-
tic and Statistical Manual ofM e n t a lD i s o r d e r s[ 2 8 ] .
Patients have to rate how they have been feeling for the
p a s tt w ow e e k s .E a c ho ft h e2 1i t e m sc o r r e s p o n d st oa
symptom of depression (e.g., concentration difficulty, loss
of energy). On 19 items there are 4 statements assessing
different severity codes of a symptom (ranging from 0-3).
On two items (16 and 18) there are 7 options (though
ranging from 0-3) to assess an increase or decrease of
appetite and sleep. A summary score of 0-13 is consid-
ered minimal depression, 14-19 mild depression, 20-28
moderate depression, and 29-63 severe depression.
The EuroQol (EQ-5D) [25]
The EuroQol is a generic non-disease-specific instrument
for valuing general health-related quality of life. The ques-
tionnaire includes single item measures of five health
dimensions: mobility, self-care, daily activities, pain and
discomfort, anxiety and depression. Each item has three
response options (no problem, some or moderate pro-
blems, extreme problems) to rate patients’ perceived
health status. In addition, the EuroQol includes a vertical
visual analogue scale ranging from 0 (worst imaginable) to
100 (best imaginable) to rate the current state of health.
Custom-made questionnaire for initial assessment
The custom-made questionnaire for initial assessment
addresses patient characteristics such as marital status,
gross family income, and claustrophobia during previous
MR imaging. The items addressed here are summarized
in Table 2.
MR imaging and image analysis
MR imaging
MR imaging will be performed in the supine position
using phased-array coils. On the open MR scanner the
following coils will be used: a large body coil for ima-
g i n go ft h es p i n e ,as m a l lf l e xc o i lf o ri m a g i n go ft h e
shoulder, and, to alleviate the feeling of confinement,
the neck coil will be used for imaging of the head (in an
upside-down position) making use of the elliptical coil
design available. If the neck coil is not tolerated for
head imaging on the open MR scanner, a multipurpose
flex coil can be used as a second alternative. On the
closed short-bore MR scanner the spine-array coils that
are integrated into the table will be used for imaging
of the spine, a small 1-channel circular polarized flex
coil will be used for imaging of the shoulder, and a
12-channel bird-cage head coil will be used for imaging
of the head. For imaging of the cervical spine, the
shoulder, and the head, patients will be examined head-
first on both scanners because feet-first imaging, which
alleviates claustrophobia by a factor of more than 10 [3],
is not possible for these diagnostic questions. For lum-
bar spine imaging, a feet-first approach can and thus
will be utilized on both scanners. Contrast-enhanced
sequences will only be obtained if clinically indicated.
On the following pages the MR sequences and their
characteristics are listed allowing a convenient compari-
son of the sequence approaches used on both MR scan-
ners for imaging of the head, spine (cervicothoracic, and
thoracolumbar), and shoulder (Tables 4, 5, 6, and 7).
For detailed information on the sequence characteristics
see Additional files 1, 2, 3, and 4. The primary aim of
the sequence setup is to obtain a voxel size that is as
similar as possible on both scanners. Differences in
acquisition time might result from this aim due to
different field strengths and gradients.
To assess patients’ anxiety before and during MR ima-
ging the State questionnaire of the State-Trait Anxiety
Inventory will be used directly before and after MR ima-
ging. The questionnaire which will be used after imaging
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Page 8 of 15is reworded in the past tense to assess patients’ anxiety
during the MR scan. This questionnaire will not be
administered if the MR procedure is terminated before
starting the scan (Figure 3).
Patients’ strategies to cope with their anxiety will be
assessed according to the Revised Ways of Coping Check-
list (RWCCL) [29]. The RWCCL is a self-report measure
of coping which is based on Lazarus’ transactional model
of stress [30]. The questionnaire consists of five scales:
problem-focused coping (15 items, e.g., “made a plan of
action and followed it”), wishful thinking (8 items, e.g.,
“daydreamed or imagined a better time or place than the
one I was in”), seeks social support (6 items, e.g.,"talked to
others and accepted their sympathy”), avoidance (10 items,
e.g., “tried to make myself feel better by eating, drinking,
smoking, taking medications”) and blamed self (3 items,
e.g., “blamed yourself). The RWCCL will not be used as a
self-report measure, but instead coping strategies will be
assessed by a study assistant, who will not influence inter-
actions between patients and radiology technicians
Table 4 Head MR imaging sequences*
Magnetom Avanto Panorama
Basic Sequences
Generic sequence name T1w SE axial
Vendor sequence name T1 SE tra T1w SE
Resulting voxel size (mm) 0.9 × 0.9 × 5.0 0.9 × 0.9 × 5.0
Acquisition time (min:sec) 3:48 4:13
Generic sequence name PD+T2w TSE axial
Vendor sequence name PD+T2 TSE tra Dual TSE
Resulting voxel size (mm) 0.9 × 0.9 × 5.0 0.9 × 1.0 × 5.0
Acquisition time (min:sec) 3:50 4:15
Generic sequence name TIRM axial
Vendor sequence name T2 TIRM tra dark-fl T2w FLAIR
Resulting voxel size (mm) 0.9 × 0.9 × 5.0 0.9 × 1.0 × 5.0
Acquisition time (min:sec) 3:38 6:36
Optional Sequences**
Generic sequence name DWI axial
Vendor sequence name Ep2 D diff3 scan trace DWI
Resulting voxel size (mm) 1.8 × 1.8 × 5.0 1.9 × 1.9 × 5.0
Acquisition time (min:sec) 0:48 0:58
Generic sequence name T2w Star axial
Vendor sequence name T2 fl2 D tra hemo T2w FFE
Resulting voxel size (mm) 0.9 × 0.9 × 5.0 0.9 × 0.9 × 5.0
Acquisition time (min:sec) 3:01 5:08
Generic sequence name T1w MPRAGE post contrast agent
Vendor sequence name T1 fl3Dsag T1w 3 D FFE
Resulting voxel size (mm) 0.9 × 0.9 × 1.0 1.0 × 1.2 × 1.0
Acquisition time (min:sec) 6:49 7:44
*For further information on the sequence characteristics see Additional file 1.
**These sequences will only be acquired if a clinical indication (e.g., for
contrast-enhanced T1-weighted sequences) exists. In all patients, however, the
basic sequences listed above will be obtained.
Abbreviations:
Dual = Double Echo.
DWI = Diffusion-Weighted Imaging.
EPI = Echo Planar Imaging.
FFE = Fast Field Echo.
FLAIR = FLuid Attenuation Inversion Recovery.
MPRAGE = Magnetization Prepared RApid Gradient Echo.
PD = Proton Density.
Sag = sagittal.
SE = Spin Echo.
T1w = T1-weighted.
T2w = T2-weighted.
TIRM = Turbo Inversion Recovery Measurement.
Tra = transverse.
TSE = Turbo Spin Echo.
Table 5 Cervicothoracic spine MR imaging sequences*
Magnetom Avanto Panorama
Basic Sequences
Generic sequence name T2w sagittal
Vendor sequence name T2 TSE rst sag T2w TSE
Resulting voxel size (mm) 0.9 × 1.0 × 3.0 1.1 × 1.1 × 3.0
Acquisition time (min:sec) 3:25 5:09
Generic sequence name T1w sagittal
Vendor sequence name T1 TSE sag T1w TSE
Resulting voxel size (mm) 1.0 × 1.5 × 3.0 1.1 × 1.5 × 3.0
Acquisition time (min:sec) 4:01 4:15
Generic sequence name T2w axial
Vendor sequence name T2 me2 D tra 3 D mFFE
Resulting voxel size (mm) 1.0 × 1.0 × 3.0 1.0 × 1.0 × 3.0
Acquisition time (min:sec) 6:53 7:38
Optional Sequences**
Generic sequence name TIRM
Vendor sequence name TIRM STIR TSE
Resulting voxel size (mm) 1.2 × 1.5 × 3.0 1.2 × 1.7 × 3.0
Acquisition time (min:sec) 5:42 5:56
Generic sequence name T1w sagittal post contrast agent
Vendor sequence name T1 TSE sag T1w TSE
Resulting voxel size (mm) 1.5 × 1.0 × 3.0 1.1 × 1.5 × 3.0
Acquisition time (min:sec) 4:01 4:15
Generic sequence name T1w axial post contrast agent
Vendor sequence name T1 TSE tra T1w TSE
Resulting voxel size (mm) 1.0 × 1.2 × 3.0 1.0 × 1.2 × 3.0
Acquisition time (min:sec) 2:16 4:12
*For further information on the sequence characteristics see Additional file 2.
**These sequences will only be acquired if a clinical indication (e.g., for
contrast-enhanced T1-weighted sequences) exists. In all patients, however, the
basic sequences listed above will be obtained.
Abbreviations:
FFE = Fast Field Echo.
Me = medic.
Sag = sagittal.
STIR = Short T1 Inversion Recovery.
T1w = T1-weighted.
T2w = T2-weighted.
TIRM = Turbo Inversion Recovery Magnitude.
Tra = transverse.
TSE = Turbo Spin Echo.
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be excluded from this questionnaire.
Furthermore, a study assistant will record important
information in an MR imaging questionnaire: scan dura-
tion, claustrophobic events, the anatomical region exam-
ined, the use of optional sequences and/or contrast
agent, the names of all staff members interacting with
the patient, assistance by the staff, any complications or
interruption during the scan, the kind of ear protection
(headphones, earplugs or none on the noise-reduced
MR scanner) as well as sedation information.
MR image analysis
MR images will be analyzed by two blinded readers on a
workstation (Centricity PACS Workstation RA 1000, GE
Healthcare). Details of the MR image analysis can be
found in the image analysis forms (Additional files 5, 6,
and 7).
Qualitative image analysis will be performed via grading
f r o m1t o5 .T h es c a l ew i l lb e1=o p t i m a l ,2=g o o d ,3=
moderate, 4 = poor, 5 = nondiagnostic to rate contrast,
contour sharpness, and overall image quality and 1 =
none, 2 = minimal, 3 = moderate, 4 = major, 5 = nondiag-
nostic to rate artifacts and noise. Artifacts will be classified
as being due to motion, pulsation, metal, noise, or other.
In shoulder imaging the fatty infiltration grade of cuff
muscles will be determined on a scale from 0 to 4 (0 = no
fat, 1 = a few streaks of fat, 2 = more muscle than fat, 3 =
as much muscle as fat, 4 = more fat than muscle) accord-
ing to Goutallier et al. [31], and the grade of muscle
Table 6 Thoracolumbar spine MR imaging sequences*
Magnetom Avanto Panorama
Basic Sequences
Generic sequence name T2w sagittal
Vendor sequence name T2 TSE rst sag T2w TSE
Resulting voxel size (mm) 0.9 × 1.0 × 3.0 1.1 × 1.1 × 3.0
Acquisition time (min:sec) 3:25 5:09
Generic sequence name T1w sagittal
Vendor sequence name T1 TSE sag T1w TSE
Resulting voxel size (mm) 1.0 × 1.5 × 3.0 1.1 × 1.5 × 3.0
Acquisition time (min:sec) 4:01 4:15
Generic sequence name T2w axial
Vendor sequence name T2 TSE rst tra T2w TSE
Resulting voxel size (mm) 0.6 × 0.8 × 4.0 0.7 × 0.8 × 4.0
Acquisition time (min:sec) 2:23 2:45
Optional Sequences**
Generic sequence name TIRM sagittal
Vendor sequence name TIRM sag STIR TSE
Resulting voxel size (mm) 1.2 × 1.5 × 3.0 1.2 × 1.7 × 3.0
Acquisition time (min:sec) 5:42 5:56
Generic sequence name T1w sagittal post contrast agent
Vendor sequence name T1 TSE sag T1w TSE
Resulting voxel size (mm) 1.0 × 1.5 × 3.0 1.1 × 1.5 × 3.0
Acquisition time (min:sec) 4:01 4:15
Generic sequence name T1w axial post contrast agent
Vendor sequence name T1 TSE tra T1w TSE
Resulting voxel size (mm) 1.0 × 1.2 × 4.0 1.0 × 1.2 × 4.0
Acquisition time (min:sec) 3:22 3:30
*For further information on the sequence characteristics see Additional file 3.
**These sequences will only be acquired if a clinical indication (e.g., for
contrast-enhanced T1-weighted sequences) exists. In all patients, however, the
basic sequences listed above will be obtained.
Abbreviations:
Sag = sagittal.
STIR = Short T1 Inversion Recovery.
T1w = T1-weighted.
T2w = T2-weighted.
TIRM = Turbo Inversion Recovery Magnitude.
Tra = transverse.
TSE = Turbo Spin Echo.
Table 7 Shoulder MR imaging sequences*
Magnetom Avanto Panorama
Basic Sequences
Generic sequence name T1w axial
Vendor sequence name T1 tra T1w TSE
Resulting voxel size (mm) 0.9 × 0.7 × 3.5 0.7 × 0.9 × 3.5
Acquisition time (min:sec) 2:17 2:47
Generic sequence name T2w axial
Vendor sequence name T2 me2 D tra 3 D mFFE WATS
Resulting voxel size (mm) 0.7 × 1.0 × 3.5 0.7 × 1.0 × 3.5
Acquisition time (min:sec) 3:19 7:11
Generic sequence name TIRM coronal
Vendor sequence name T1 TIRM cor STIR
Resulting voxel size (mm) 0.6 × 0.8 × 4.0 0.6 × 0.9 × 4.0
Acquisition time (min:sec) 5:15 6:36
Generic sequence name PD+T2w TSE coronal
Vendor sequence name PD+T2 TSE cor Dual dr tsetse
Resulting voxel size (mm) 0.6 × 0.8 × 4.0 0.6 × 0.8 × 4.0
Acquisition time (min:sec) 4:16 5:59
Generic sequence name T2w TSE parasagittal
Vendor sequence name T2 TSE rst fs parasag T2 TSE SPIR
Resulting voxel size (mm) 0.7 × 0.9 × 4.0 0.7 × 0.9 × 4.0
Acquisition time (min:sec) 4:04 4:52
*For further information on the sequence characteristics see Additional file 4.
Abbreviations:
Cor = coronal.
Dual = Double echo.
FFE = Fast Field Echo.
Me = medic.
Parasag = parasagittal.
PD = Proton Density.
Sag = sagittal.
SPIR = Spectral Presaturation Inversion Recovery.
STIR = Short T1 Inversion Recovery.
T1w = T1-weighted.
T2w = T2-weighted.
TIRM = Turbo Inversion Recovery Magnitude.
Tra = transverse.
TSE = Turbo Spin Echo.
WATS = WATer only Selection.
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0t o4( 0=n o n e ,2=m i l d ,3=m o d e r a t e ,4=s e v e r e )
according to Warner et al. [32]. In addition, the permitted
diagnostic quality of assessment of rotator cuff muscles
and their ligaments (coronal imaging) and the glenoid lab-
rum (axial imaging) will be determined via grading from
0 to 5 (1 = optimal, 2 = good, 3 = moderate, 4 = poor and
5 = nondiagnostic).
Quantitative image analysis will be performed via
measurements of signal intensities (SI) in circular
regions of interest (ROI) ranging in size from 0.02 up to
0.4 cm² standardized according to the anatomy. Mean
values and standard deviations will be calculated for
each measurement in each standard sequence of either
head, spine, or shoulder MR imaging. Standard devia-
tions (SD) of the ROI signals will be used to measure
noise, and signal-to-noise and contrast-to-noise ratios
were calculated as recently described [33]. Furthermore,
contour clarity will be analyzed as recently described
[34], using ImageJ http://rsbweb.nih.gov/ij/. Contour
clarity in head imaging will be distinguished between
corticospinal fluid, caudate nucleus, and genu of corpus
callosum. In spine imaging, contour clarity will be deter-
mined for gray and white matter of the spinal cord, cor-
ticospinal fluid, and vertebral body. In shoulder imaging,
it will be determined for joint fluid and glenoid labrum
(axial images), for fat and muscle (deltoideus), and for
bone marrow (humerus head).
Need for further improvements
A custom-made questionnaire will be used to track cer-
tain features of the MR procedure (e.g., pain and noise)
and patient preferences concerning MR scanner design
and which specific scanner design patients consider
most attractive (Figure 1). This information is important
to be able to define which further improvements by
vendors might be necessary to reduce claustrophobic
reactions during MR imaging. In Table 1 we have
summarized the main objectives addressed in this
questionnaire.
Follow-up after 4 to 6 weeks
At the initial follow-up, the STAI [18], AKV [19], FSS-
III [20], and CLQ [21] questionnaires will be repeated.
The State questionnaire of the STAI will be repeated in
two versions assessing the current state of anxiety and
the state of anxiety during MR imaging (if accomplished
without sedation).
Follow-up after 7 months
At the final follow-up, the STAI [18], AKV [19], FSS-III
[20], CLQ [21], BDI-II [24], and EuroQol [25] question-
naires will be repeated. The State questionnaire of the
STAI will be repeated in two versions assessing the
current state of anxiety and the state of anxiety during
MR imaging (if accomplished without sedation). More-
over, a custom-made questionnaire will be administered
to assess clinical outcome, development of claustropho-
bic anxiety, and general satisfaction with the study parti-
cipation. The items addressed here are summarized in
Table 3.
Discussion
Patients with claustrophobic anxiety, who are more
likely to be frightened during MR imaging, have been
reported to experience claustrophobia in up to 35% of
all examinations [6]. To complete the scan, conscious
sedation and additional sequences (after sedation) may
be necessary in these patients. This situation involves
significant risks of adverse events [7-9] and is associated
with additional costs because it reduces workflow, limits
patient acceptance, and wastes valuable scanning time
and thus induces costs. On the other hand, prematurely
terminated scans as well mean an important financial
loss for the health care system. Improved patient com-
fort during MR imaging (mainly reduction of noise and
sensation of confinement) appears to be essential to
avoid claustrophobic reactions [10,11].
A more patient-centered design of closed MR systems
is one effective approach to make MR imaging more
comfortable for patients. Few studies have investigated
patient acceptance and the potential to reduce claustro-
phobic anxiety of recent closed MR scanners with noise
reduction and short- and wide-bore design in compari-
son to conventional MR scanners.
In a large cohort study of 55,734 outpatients, Dewey
et al. assessed the potential to reduce claustrophobia of
a recent 1.5-T MR scanner with 97% noise reduction
and a short- and wide-bore design [3]. Patients were
examined on either the recent or a conventional MR
scanner. The recent MR scanner was shown to reduce
claustrophobia by a factor of 3, although there were
more head-first examinations on that scanner. Intraindi-
vidual comparisons of patients who underwent imaging
on both MR units showed similar results with a claus-
trophobia rate of below 1% [3].
In a retrospective study on the occurrence of claustro-
phobia in 5,682 patients examined on either a 1.5-T
closed MR scanner or a 0.5-T noise-reduced MR scan-
ner with a short and wide bore Dantendorfer et al.
found no significant difference between the two MR
units [35]. However, there was a selection bias because
staff was referring highly anxious patients to the recent
MR scanner. Thus, the authors conclude that the short-
bore MR scanner may in fact reduce claustrophobia
[35]. In a later study by Dantendorfer et al., 297 patients
without MR imaging experience were randomly exam-
ined on either a 1.5-T closed MR scanner or a recent
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bore [36]. Anxiety before and after the scan was among
others assessed using the State questionnaire of the
STAI. Although patients felt more at ease in the recent
MR scanner (concerning noise and confinement), there
was no significant difference in patient acceptance and
occurrence of motion artifacts. Interestingly, there was
no correlation between STAI scores and motion arti-
facts, but patients who were more concerned about the
technical apparatus had more motion artifacts [36].
Another approach to improve patient acceptance of
MR imaging is a more open vertical scanner configura-
tion, although until recently such systems operated at
rather low field strengths (0.2 T), resulting in poor
image quality.
Heuck et al. compared two high-field closed MR sys-
tems operating at 1.5-T and 1.0-T with an open whole-
body scanner and a dedicated extremity MR system,
both operating at 0.2-T [37]. In 40 patients examined
on each system (160 total) they found a mainly positive
condition and acceptance for all MR scanners. However,
patients who were examinedo nt h eo p e nM Rs c a n n e r s
felt significantly more confident and calm, despite
longer examination durations. Patients’ suggestions for
improvement of the high-field closed MR systems
mainly concerned reduction of noise and enlargement of
the bore. Nevertheless, these authors concluded that the
necessary technical conditions and not differences in
patient preference should be crucial for the choice of an
MR system [37].
In a recent pilot study Bangard et al. have examined
36 claustrophobic and 36 non-claustrophobic patients
on a recently introduced open MR scanner with high-
field strength (1.0 T) [14]. Anxiety was assessed using
validated questionnaires (STAI, CLQ, MRI FSS [26]). In
the claustrophobic patients scan termination rate was
reduced to 8% compared to 58.3% in previous examina-
tions on conventional MR systems, and 91.7% preferred
the open MR scanner. Furthermore, claustrophobia did
not reduce image quality by motion artifacts [14].
A 0.5-T interventional MR scanner with a vertical gap
in the bore of the magnet ("double donut”)w a su s e di n
a study by Spouse et al. [13]. 96% of 50 claustrophobic
patients who were unable to complete a conventional
MR scan successfully underwent MR imaging on the
interventional scanner. Patients reported less anxiety
than during their previous MR imaging and felt signifi-
cantly better informed about the procedure. However,
friends or relatives were allowed to stay in the magnet
room and many patients indicated that this, beside the
scanner design, had helped them considerably [13].
In contrast to the above mentioned studies, the
CLAUSTRO trial will directly compare an open MR
scanner with a vertical 1.0-T magnetic field, and a
closed noise-reduced MR scanner with a short- and
wide-bore design and 1.5-T field strength in regards to
claustrophobia and image quality as well as influence on
further clinical management in a randomized controlled
trial. Patients included will have at least moderate levels
of claustrophobic anxiety, experienced claustrophobia
during a prior MR imaging or rejected a current sched-
uled MR imaging due to claustrophobia, and will have a
clinical indication for MR imaging and will thus be at
high risk to experience claustrophobia during the MR
scan. Anxiety will be assessed before and after MR ima-
ging as well as 4-6 weeks and 7 months after the scan
in order to address the development of claustrophobia.
Increase of claustrophobic anxiety has been found if the
scan is terminated prematurely or high anxiety is toler-
ated [26,38-40]. On the other hand, there are reports of
decreased anxiety after completed MR imaging [40,41].
Long-term alleviation of claustrophobia after completed
MR imaging might support the potential of exposure
therapy to treat claustrophobia [42,43]. To perform the
comparison of image quality as reliable as possible the
anatomical regions to be examined will be limited to
head, spine and shoulder, and equal sequences on both
scanners with comparable voxel sizes will be utilized.
Diagnostic utility and clinical outcome will be assessed
7 months after MR imaging which is an appropriate
time-frame to detect an influence on clinical manage-
ment. Of course this will be mediated through the
patients and referring physicians’ response to MR
results. Furthermore, the study will address which speci-
fic scanner design is evaluated by patients to be the
most attractive and which further improvements in
designing MR scanners should be followed by manufac-
turers. Randomization will be done as the most decisive
evidence for judging the efficacy of diagnostic tests
comes from randomized comparisons in which the con-
trolled design obviates the biases of observational stu-
dies [15,16]. Patients who are assigned to imaging in
one MR scanner but cannot bear this procedure due to
claustrophobic anxiety will be cross-referred to imaging
in the other scanner in order to preclude adverse events
associated with sedation [7-9]. This will also allow direct
comparison of the two options in those patients as an
ancillary study. Due to its design this trial will also be
able to analyze and compare the cost-effectiveness of
the two MR scanners.
Study limitations
Anxiety during MR imaging can occur due to several
other psychosomatic or psychiatric disorders than claus-
trophobia e.g., panic disorder, adjustment disorder with
anxious mood, or major depression [10]. Within the
limits of the study, claustrophobia will not be diagnosed
according to ICD-10 or DSM-IV criteria [28,44].
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and the patient which can contribute to anxiety beyond
confinement by the MR scanner. Such features may be
pain, loud noise, the unknown, concerns about diagnos-
tic findings, having to lie still, the examination duration,
uncomfortable temperature or the MR scanner itself
[5,11,45-47]. Several studies have shown that especially
pain is correlated with anxiety during the scan and pre-
mature termination [11,38,40]. However, claustrophobia
will be assessed using the CLQ [21], and reaching a spe-
cific score is an inclusion criterion (an arithmetic mean
of greater or equal 1.0 must be reached by rating anxiety
o nas c a l ef r o m1t o4f o re a c ho f2 6i t e m s ) .F u r t h e r -
more, a custom-made questionnaire addressing prior
claustrophobic events before or during scheduled MR
imaging and first occurrence of claustrophobia will be
fulfilled by a study assistant in the manner of a struc-
tured interview. Further questionnaires will help to
examine generalized anxiety, patients’ health status
(including pain) and depression symptoms. The pain
and noise levels which patients experience during MR
imaging will be assessed directly after the scan by using
horizontal visual analogue scales and patients will be
asked to report whether they are afraid of diagnostic
findings in MR imaging. Claustrophobia as part of e.g., a
panic disorder is no exclusion criterion. However,
patients will be asked to report whether they have
known psychosomatic or psychiatric disorders. In gen-
eral, in the majority of articles addressing anxiety lead-
ing to premature termination of MR imaging, anxiety is
referred to as “claustrophobia” [5]. For the assessment
of anxiety during MR imaging it is also important to
know whether patients take any anxiolytic or sedative
drugs or other psychotropics which will thus be exam-
ined. Different examination times (due to different
sequence duration, anxiety or complications) and differ-
ent coils will also be assessed.
Another feature of MR imaging whose influence on
patients’ condition will be difficult to measure is the sup-
port by nursing stuff, radiographers and physicians. Sev-
eral studies have shown the importance of social support
and the appreciation of a caring attitude of others by
anxious patients [13,47-49]. It might yet influence
patients to know that staff is aware of their anxiety and
the staff may act more caring because of this awareness.
However, patients’ seeking social support will be assessed
by evaluating coping strategies and patients will be asked
to report what did particularly help them to cope with
their anxiety. Furthermore, the staff will be instructed
not to be “overprotective” and not to suggest coping stra-
tegies to the patients. Of course, patients will experience
more attendance than in clinical routine. To keep the
influence as constant as possible, patients will mainly be
attended by two female staff members throughout the
study and there will be a limited number of physicians
and radiographers who perform MR imaging.
With regard to the comparison of image quality, the
primary aim of the sequence set-up is to obtain a voxel
size that is as similar as possible on both MR scanners.
Thus, compromises have to be made concerning the
best possible image quality still providing comparability.
Motion artifacts due to anxiety might also play a role
[45,50] but should be obviated by the high number of
patients and randomization.
Concerning the closed MR scanner with short- and
wide-bore design which will be used in this study, it
should be mentioned that there are scanners with even
shorter and wider bores like the Siemens Magnetom
Espree with 0,7 m diameter and 1,25 m length of the
scanner bore. However, this improvement in scanner
design affects the image quality which can be achieved
with this MR scanner.
Conclusions
This randomized controlled trial will be the first direct
comparison of open vertical and closed short-bore MR
systems in regards to claustrophobia and image quality
as well as diagnostic utility. If an open MR scanner can
be shown to reduce claustrophobia in a randomized
comparison it might be justified to recommend this
approach for routine clinical application in certain high-
risk anxiety patients or in certain imaging centers.
Furthermore, it is the first study to address which speci-
fic scanner design is evaluated by patients to be the
most attractive for imaging. This knowledge is impor-
tant to be able to define which further improvements by
the vendors might be necessary to reduce claustrophobic
reactions. Accordingly, this randomized trial has the
potential to influence both the clinical and economical
utilization and impact of MR imaging.
Additional material
Additional file 1: Appendix Table S1. Further information on head MR
imaging sequences used.
Additional file 2: Appendix Table S2. Further information on
cervicothoracic spine MR imaging sequences used.
Additional file 3: Appendix Table S3. Further information on
thoracolumbar spine MR imaging sequences used.
Additional file 4: Appendix Table S4. Further information on shoulder
MR imaging sequences used.
Additional file 5: Appendix Figure S1. MR image analysis form for
quantitative and qualitative analysis of head imaging.
Additional file 6: Appendix Figure S2. MR image analysis form for
quantitative and qualitative analysis of spine imaging.
Additional file 7: Appendix Figure S3. MR imaging analysis form for
quantitative and qualitative analysis of shoulder imaging.
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